Igc Pharma Inc (IGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -536 | 195 | -375 | 1,359 | 1,287 |
| Depreciation Amortization | 450 | 876 | 683 | 470 | 232 |
| Income taxes - deferred | 44 | 221 | 223 | 196 | 130 |
| Accounts receivable | -695 | -2,725 | -5,694 | -6,053 | -4,685 |
| Accounts payable and accrued liabilities | 855 | -1,033 | 243 | 2,113 | 1,009 |
| Other Working Capital | -634 | -10,068 | -7,223 | -10,193 | -7,100 |
| Other Operating Activity | 46 | 4,421 | 5,850 | 4,338 | 3,642 |
| Operating Cash Flow | $-470 | $-8,114 | $-6,293 | $-7,770 | $-5,486 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 1 | -85 | -1,721 | -3,679 |
| PPE Investments | N/A | -2,005 | -1,844 | -1,928 | -1,588 |
| Net Acquisitions | N/A | 221 | N/A | N/A | N/A |
| Purchase Of Investment | N/A | 1,395 | 1,425 | N/A | N/A |
| Other Investing Activity | -242 | 3,273 | 3,117 | 2,992 | 11 |
| Investing Cash Flow | $-242 | $2,885 | $2,612 | $-657 | $-5,256 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 560 | -1,215 | -2,153 | 2,601 | 2,414 |
| Debt Issued | -645 | N/A | 3,192 | 2,000 | 1,699 |
| Debt Repayment | N/A | 179 | -569 | -3,975 | -1,174 |
| Common Stock Issued | N/A | 298 | N/A | N/A | N/A |
| Other Financing Activity | -248 | 583 | -2,756 | 2,302 | 1,214 |
| Financing Cash Flow | $-332 | $-156 | $-2,286 | $2,928 | $4,153 |
| Exchange Rate Effect | 38 | -884 | -692 | -420 | -259 |
| Beginning Cash Position | 2,129 | 8,397 | 8,397 | 8,397 | 8,397 |
| End Cash Position | 1,123 | 2,129 | 1,739 | 2,478 | 1,550 |
| Net Cash Flow | $-1,006 | $-6,268 | $-6,658 | $-5,919 | $-6,848 |
| Free Cash Flow | |||||
| Operating Cash Flow | -470 | -8,114 | -6,293 | -7,770 | -5,486 |
| Capital Expenditure | N/A | -2,493 | -1,844 | -1,928 | N/A |
| Free Cash Flow | -470 | -10,607 | -8,137 | -9,698 | -5,486 |